Brazilian Regulator Consults On Improving Rules For Registering Biosimilars

 
• By Francesca Bruce

ANVISA, Brazil’s medicines regulator, is asking for feedback on the regulatory pathway for biosimilars.

Brazil Flag
Brazil Consults On Biosimilar Regulatory Pathway • Source: Shutterstock

More from Biosimilars

More from Products